James Golubieski, president of Foundation Venture Capital Group, says it invested in GeneAssess because a gene it has identified appears to be found in breast cancer, but also shows potential for other cancers.

Foundation Venture Capital Group, a venture firm which invests in start-ups run by faculty at or affiliated with the University of Medicine and Dentistry of New Jersey, has invested $500,000 in GeneAssess, a cancer research company, which has discovered a gene named "FRY" which it believes can help detect cancer. James Golubieski, president of Foundation…

The rest of this content is only accessible to Global Venturing Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.